Stay updated on Opregen in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.

Latest updates to the Opregen in Geographic Atrophy Clinical Trial page
- Check5 days agoChange DetectedA new 'Last Update Posted (Estimated)' field has been added to the Study Record Dates, and the previous 'Last Update Posted' field has been removed.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded an auto-fill note for Publications indicating PubMed-derived articles may not be related to the study, and updated last update information and revision to v3.3.2; previous PubMed notes and an estimated update timestamp were removed.SummaryDifference0.4%

- Check19 days agoChange DetectedRemoved the government funding status notice, a non-critical item, while core study details remain unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedThe new screenshot shows updates to the study record metadata (last update date) and minor wording changes in the Study Overview. These changes do not alter core study details or participant eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedNew recruitment sites were added: Retina Consultants of Texas (Bellaire, TX) and Retina Vitreous Associates of Florida (St. Petersburg, FL). The total number of locations is updated to 15.SummaryDifference0.7%

- Check62 days agoChange DetectedCore content updated to include a government funding notice and new revision/version, signaling a status update; previous versioning line items were replaced with newer ones.SummaryDifference5%

Stay in the know with updates to Opregen in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.